We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

002648:SZSESatellite Chemical Co. Ltd. Class A Analysis

Data as of 2026-03-17 - not real-time

CN¥25.99

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Satellite Chemical is trading at CNY 25.99, comfortably above its 20‑day SMA of 24.95 and 50‑day SMA of 22.22, signaling a sustained uptrend. The MACD line sits at 1.53 above the signal line, producing a bullish histogram, while the 14‑day RSI of 55 indicates neither overbought nor oversold conditions. Daily volume has been rising, supporting the price advance, and the technical support sits around 22.10 with resistance near 30.00, giving the stock a clear upside corridor. Market sentiment is in the “Extreme Greed” zone (fear‑greed index 81.5), further fueling buying pressure. Overall, the price action aligns with a bullish technical profile.
Fundamentally, the stock trades at a forward‑PE of 13.96 and a trailing‑PE of 14.94, modest multiples for a specialty chemicals player with a 20.5% ROE and a solid 12.7% profit margin. The dividend yield of 1.85% and a low payout ratio of 27% are underpinned by strong operating cash flow (CNY 11.5 bn) and free cash flow (CNY 9.2 bn). Although revenue fell 12.2% YoY, the company maintains a gross margin of 22.4% and a healthy cash balance of 7.4 bn, offsetting a high debt‑to‑equity ratio of 78%. A discounted cash‑flow model suggests a fair value of CNY 31.93, implying upside potential beyond the current level. Analysts rate the stock as a “strong buy” with a mean target of CNY 25.34, reinforcing the positive outlook.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Bullish MACD with positive histogram
  • Price above 20‑day and 50‑day SMAs
  • Rising trading volume supporting momentum

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • DCF fair value indicating ~20% upside
  • Strong ROE and cash flow generation
  • Attractive dividend yield with low payout ratio

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Exposure to growth segments like new energy materials
  • High debt‑to‑equity ratio requiring monitoring
  • Valuation converging toward fair value

Key Metrics & Analysis

Financial Health

Revenue Growth-12.20%
Profit Margin12.74%
P/E Ratio14.9
ROE20.46%
ROA7.35%
Debt/Equity78.41
P/B Ratio2.7
Op. Cash FlowCN¥11.5B
Free Cash FlowCN¥9.2B

Technical Analysis

TrendBullish
RSI55.6
SupportCN¥22.10
ResistanceCN¥30.00
MA 20CN¥24.95
MA 50CN¥22.22
MA 200CN¥19.06
MACDBullish
VolumeIncreasing
Fear & Greed Index81.54

Valuation

Fair ValueCN¥31.93
Target PriceCN¥25.34
Upside/Downside-2.50%
GradeUndervalued
TypeBlend
Dividend Yield1.85%

Risk Assessment

Beta0.19
Volatility68.78%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.